1. Home
  2. YUMC vs MDGL Comparison

YUMC vs MDGL Comparison

Compare YUMC & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yum China Holdings Inc.

YUMC

Yum China Holdings Inc.

HOLD

Current Price

$42.61

Market Cap

14.8B

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$543.16

Market Cap

12.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YUMC
MDGL
Founded
1987
2011
Country
China
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.8B
12.8B
IPO Year
2016
2005

Fundamental Metrics

Financial Performance
Metric
YUMC
MDGL
Price
$42.61
$543.16
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
$674.45
AVG Volume (30 Days)
1.3M
221.6K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
2.38%
N/A
EPS Growth
7.73
N/A
EPS
1.57
N/A
Revenue
$11,797,000,000.00
$180,133,000.00
Revenue This Year
$9.42
$58.39
Revenue Next Year
$5.86
$48.55
P/E Ratio
$27.61
N/A
Revenue Growth
4.37
N/A
52 Week Low
$40.15
$393.61
52 Week High
$58.39
$615.00

Technical Indicators

Market Signals
Indicator
YUMC
MDGL
Relative Strength Index (RSI) 31.13 55.22
Support Level $42.46 $529.02
Resistance Level $49.58 $566.70
Average True Range (ATR) 1.03 17.10
MACD -0.59 1.29
Stochastic Oscillator 3.92 79.07

Price Performance

Historical Comparison
YUMC
MDGL

About YUMC Yum China Holdings Inc.

Yum China is the largest restaurant operator in China, with over 18,000 locations and USD 12 billion in systemwide sales as of 2025. It generates revenue primarily from its own restaurants and franchise fees. While KFC and Pizza Hut are its flagship brands, Yum China's portfolio also includes Little Sheep, Taco Bell, Huang Ji Huang, and Lavazza.As a trademark licensee of Yum Brands, Yum China pays 3% of KFC and Pizza Hut's systemwide sales to its former parent, from which it spun off in 2016. However, even before the separation, Yum China was granted substantial autonomy, giving its Chinese leadership decision-making authority over menu, supply chain, and marketing—an unusual practice for Western chains at the time.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: